Literature DB >> 21637926

Restored expression of the tumor suppressor gene RUNX3 reduces cancer stem cells in hepatocellular carcinoma by suppressing Jagged1-Notch signaling.

Shin-Ichi Nishina1, Hidenori Shiraha, Yutaka Nakanishi, Shigetomi Tanaka, Minoru Matsubara, Nobuyuki Takaoka, Masayuki Uemura, Shigeru Horiguchi, Junro Kataoka, Masaya Iwamuro, Takahito Yagi, Kazuhide Yamamoto.   

Abstract

Runt-related transcription factor 3 (RUNX3) is a candidate tumor suppressor gene that is downregulated in various cancers. In the present study, we analyzed the regulatory function of RUNX3 on Jagged-1 (JAG1) expression and cancer stem cell (CSC) signaling in hepatocellular carcinoma (HCC). Eleven HCC cell lines and 30 human HCC tissues were used. RUNX3 and JAG1 expression levels were analyzed by immunoblotting and immunohistochemistry. Ectopic RUNX3 expression was induced by introducing RUNX3 cDNA into the RUNX3-negative HCC cell line Hep3B and Huh7 cells. Furthermore endogenous RUNX3 expression was knocked down by RUNX3 siRNA in SK-Hep-1 cells. In order to analyze JAG1 transcriptional regulation, we conducted reporter assays, chromatin immunoprecipitation (ChIP) assays and electrophoretic mobility shift assays (EMSAs). Tumorigenicity was analyzed using a SCID mouse liver injection model. An inverse correlation was observed between RUNX3 expression and JAG1 expression in most HCC cell lines and tissues. Restoring RUNX3 expression decreased the expression of JAG1 in Hep3B and Huh7 cells, whereas JAG1 expression was upregulated in RUNX3 siRNA-treated SK-Hep-1 cells. Reporter assays, ChIP assays and EMSAs revealed that RUNX3 directly bound to the transcriptional regulatory region of JAG1 and suppressed JAG1 transcription. Moreover, RUNX3 restoration downregulated CSCs by suppressing JAG1-mediated Notch signaling. The tumorigenic capacity of RUNX3-expressing Hep3B cells was lower compared to that of control Hep3B cells. RUNX3 expression suppressed JAG1 expression and resulted in downregulation of tumorigenesis by suppression of JAG1-mediated CSCs.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21637926     DOI: 10.3892/or.2011.1336

Source DB:  PubMed          Journal:  Oncol Rep        ISSN: 1021-335X            Impact factor:   3.906


  20 in total

1.  Inactivation of RUNX3 predicts poor prognosis in esophageal squamous cell carcinoma after Ivor-Lewis esophagectomy.

Authors:  Mo Shi; Zhou Wang; Xiang-Yan Liu; Dong Chen
Journal:  Med Oncol       Date:  2014-11-13       Impact factor: 3.064

2.  Molecular mechanism of increased sensitivity of cisplatin to ovarian cancer by inhibition of microRNA-23a expression.

Authors:  Ai-Hong Jin; Zhao-Lian Wei
Journal:  Int J Clin Exp Med       Date:  2015-08-15

Review 3.  Emerging roles of the FBW7 tumour suppressor in stem cell differentiation.

Authors:  Zhiwei Wang; Hiroyuki Inuzuka; Hidefumi Fukushima; Lixin Wan; Daming Gao; Shavali Shaik; Fazlul H Sarkar; Wenyi Wei
Journal:  EMBO Rep       Date:  2011-12-23       Impact factor: 8.807

4.  Runx1 is a tumor suppressor gene in the mouse gastrointestinal tract.

Authors:  Remond J A Fijneman; Rebecca A Anderson; Ethan Richards; Jieming Liu; Marianne Tijssen; Gerrit A Meijer; Janae Anderson; Annette Rod; Michael G O'Sullivan; Patricia M Scott; Robert T Cormier
Journal:  Cancer Sci       Date:  2012-01-19       Impact factor: 6.716

Review 5.  The Notch signaling pathway as a mediator of tumor survival.

Authors:  Kathleen M Capaccione; Sharon R Pine
Journal:  Carcinogenesis       Date:  2013-04-12       Impact factor: 4.944

6.  Tumor suppressor genes are differentially regulated with dietary folate modulations in a rat model of hepatocellular carcinoma.

Authors:  Renuka Sharma; Taqveema Ali; Jyotdeep Kaur
Journal:  Mol Cell Biochem       Date:  2020-09-24       Impact factor: 3.396

Review 7.  Regulation of angiogenesis via Notch signaling in breast cancer and cancer stem cells.

Authors:  Weiqiang Zhou; Guangdi Wang; Shanchun Guo
Journal:  Biochim Biophys Acta       Date:  2013-10-30

8.  Hepatic stellate cells promote upregulation of epithelial cell adhesion molecule and epithelial-mesenchymal transition in hepatic cancer cells.

Authors:  Teruya Nagahara; Hidenori Shiraha; Hiroaki Sawahara; Daisuke Uchida; Yasuto Takeuchi; Masaya Iwamuro; Junro Kataoka; Shigeru Horiguchi; Takeshi Kuwaki; Hideki Onishi; Shinichiro Nakamura; Akinobu Takaki; Kazuhiro Nouso; Kazuhide Yamamoto
Journal:  Oncol Rep       Date:  2015-07-13       Impact factor: 3.906

9.  Loss of Runt-related transcription factor 3 induces resistance to 5-fluorouracil and cisplatin in hepatocellular carcinoma.

Authors:  Junro Kataoka; Hidenori Shiraha; Shigeru Horiguchi; Hiroaki Sawahara; Daisuke Uchida; Teruya Nagahara; Masaya Iwamuro; Hiroki Morimoto; Yasuto Takeuchi; Kenji Kuwaki; Hideki Onishi; Shinichiro Nakamura; Akinobu Takaki; Kazuhiro Nouso; Takahito Yagi; Kazuhide Yamamoto; Hiroyuki Okada
Journal:  Oncol Rep       Date:  2016-03-16       Impact factor: 3.906

Review 10.  The notch ligand JAGGED1 as a target for anti-tumor therapy.

Authors:  Demin Li; Massimo Masiero; Alison H Banham; Adrian L Harris
Journal:  Front Oncol       Date:  2014-09-25       Impact factor: 6.244

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.